The Scientist

» miRNA, disease/medicine and microbiology

Most Recent

image: Protein or Perish

Protein or Perish

By | September 1, 2016

A bacteriophage must evolve certain variants of a protein or die.

0 Comments

image: One Receptor, Two Ligands, Different Responses

One Receptor, Two Ligands, Different Responses

By | August 31, 2016

Host and bacterial ligands that interact with the same cell-surface receptor induce different activities in human macrophages. 

0 Comments

image: One Antigen Receptor Induces Two T cell Types

One Antigen Receptor Induces Two T cell Types

By | August 26, 2016

Precursor T cells bearing the same antigen receptor adopt two different fates in mice.

1 Comment

image: Polio Reemerges in Nigeria

Polio Reemerges in Nigeria

By | August 15, 2016

Prior to last week’s announcement of newly confirmed cases, the country had been polio-free for two years.

1 Comment

image: Antibiotic Resistance Reaches Brazil

Antibiotic Resistance Reaches Brazil

By | August 8, 2016

Scientists detect a colistin-resistance gene in a clinical sample.

0 Comments

image: Fecal Transplant Pill Fails Trial

Fecal Transplant Pill Fails Trial

By | August 1, 2016

Seres Therapeutics’s microbiome-targeting therapy for recurrent Clostridium difficile infection fails a Phase 2 clinical trial.

2 Comments

From sequencing bacteriophages to synthesizing bacterial genomes to defining a minimal genome

0 Comments

image: Cullen Buie Parses Pathogens With Passion

Cullen Buie Parses Pathogens With Passion

By | August 1, 2016

Associate Professor, Department of Mechanical Engineering, MIT. Age: 34

1 Comment

By ditching traditional agar-based media, two biochemists captured iconic images of Myxococcus in 1982.

0 Comments

image: Moving Toward Personalized Autism Treatment

Moving Toward Personalized Autism Treatment

By | August 1, 2016

Researchers aim to leverage new insights into the underlying causes of the disorder to better help patients. 

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech